Abstract
Alzheimer’s Disease (AD) is a neurodegenerative disorder characterized by a complex array of neuropathological, biochemical, and behavioral sequelae (Folstein and Whitehouse, 1983). AD is a recognized socioeconomic problem that has significant effects on a large percentage of an increasingly more aged population. Numerous experimental studies have been designed to investigate its etiology and possible pharmacotherapies for its treatment. Experimental animal models of AD are designed to reproduce a subset of the neuropathological, biochemical, and behavioral changes that have been identified in the brains of patients with AD. These animal models are, of course, inadequate because they do not completely reproduce all of the pathological and biochemical changes associated with AD; however, each model has been useful for the investigation of specific aspects of the disease. This chapter will outline the many experimental animal models of AD and compare the advantages and disadvantages of specific methodological approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aigner T. G., Mitchell S. J., Aggleton J. P., DeLong M. R., Struble R. G., Price D. L., Wenk G. L., and Mishkin M. (1987) Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert. Psychopharmacology 92, 292–300.
Allen Y. S., Marchbanks R. M., and Sinden J. D. (1988) Non-specific effects of the putative cholinergic neurotoxin ethylcholine mustard aziridinium ion in the rat brain examined by autoradiography, immunocytochemistry and gel electrophoresis. Neurosci. Lett. 95, 69–74.
Arendash G. W., Millard W. J., Dunn A. J., and Meyer E. M. (1987) Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science 238, 952–956.
Arendt T., Bigl V., Tennstedt A., and Arendt A. (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer’s disease. Neuroscience 14, 1–14.
Atack J. R., Wenk G. L., Wagster M. V., Kellar K. J., Whitehouse P. J., and Rapoport S. I. (1989) Bilateral changes in neocortical [3H]pirenzepine and [3H]oxotremorine-M binding following unilateral lesions of the rat nucleus basalis magnocellularis: an autoradiographic study. Brain Res. 483, 367–372.
Bartus R. T., Dean R. L., Beer B., and Lippa A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408–417.
Bartus R. T., Fleming D., and Johnson H. R. (1978) Aging in the rhesus monkey: debilitating effects on short-term memory. J. Gerontol. 33, 858–871.
Bartus R. T., Flicker C., Dean, R. L., Pontecorvo M., Figuerdo J. C., and Fisher S. K. (1985) Selective memory loss following nucleus basalis lesions: long term behavioral recovery despite persistent cholinergic deficiencies. Pharmacol. Biochem. Behav. 23, 125–135.
Beal M. F., Mazurek M. F., Ellison D. W., Kowall N. W., Soloman P. R., and Pendlebury W. W. (1989) Neurochemical characteristics of aluminum-induced neurofibrillary degeneration in rabbits. Neuroscience 2, 329–337.
Beninger R. J., Jhamandas K., Boegman R. J., and El-Defrawy S. R. (1986) Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats. Pharmacol. Biochem. Behav 24, 1353–1360.
Bertholf R. L. (1987) Aluminum and Alzheimer’s disease: Perspectives for a cytoskeletal mechanism. CRC Crit. Rev. Clin. Lab. Sci. 25, 195–210.
Blessed G., Tomlinson B. E., and Roth M. (1968) The association between quantitative measures of dementia and of senile change in the grey matter of elderly subjects. Br. J. Psychiat. 114, 797–811.
Borson S., Barnes R. F., Veith R. C., Halter J. B., and Rasking M. A. (1989) Impaired sympathetic nervous system response to cognitive effort in early Alzheimer’s disease. J. Gerontol., 44, M8–12.
Bowen D. M., Spillane J. A., Curzon G., Meier-Ruge W., White P., Goodhardt M. J., Iwangoff P., and Davison A. N. (1979) Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet 1, 11–14.
Broks P., Preston G. C., Traub M., Poppleton P., Ward C., and Stahl S. M. (1988) Modelling dementia: effects of scopolamine on memory and attention. Neuropsychology 5, 685–700.
Casamenti F., DePatre P. L., Bartolini L., and Pepeu G. (1988) Unilateral and bilateral nucleus basalis lesions: Differences in neurochemical and behavioral recovery. Neuroscience 2, 209–215.
Chrobak J. J., Hanin L, Schmechel D. E., and Walsh T. J. (1988) AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res. 463, 107–117.
Chrobak J. J., Hanin I., and Walsh T. J. (1987) AF64A (ethylcholine aziridinium ion), a cholinergic neurotoxin, selectively impairs working memory in a multiple component T-maze task. Brain Res. 414, 15–21.
Chui H. C., Bondareff W., Zarow C., and Slager U. (1984) Stability of neuronal number in the human nucleus basalis of Meynert with age. Neurobiol. Aging 5, 83–88.
Coffey P. J., Perry V. H., Allen Y., Sinden J., and Rawlins J. N. P. (1988) Ibotenic acid induced demyelination in the central nervous system: a consequence of a local inflammatory response. Neurosci. Lett. 84, 178–184.
Collerton D. (1986) Cholinergic function and intellectual decline in Alzheimer’s disease. Neuroscience 19, 1–28.
Cotman C. W. and Iversen L. L. (1987) Excitatory amino acids in the brain—focus on NMDA receptors. Trends Neurosci. 10, 263–280.
Coyle J. T. (1983) Neurotoxic action of kainic acid. J. Neurochem. 41, 1–11.
Coyle J. T. and Schwartz R. (1983) The use of excitatory amino acids as selective neurotoxins, in Handbook of Chemical Neuroanatomy. Vol. 1: Methods in Chemical Neuroanatomy (Borklund A. and Hokfelt T., eds.), pp. 508–527. Elsevier, New York.
Coyle J. T., Price D. L., and DeLong M. R. (1983) Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science 219, 1184–1190.
Craik F. I. M. (1977) Age differences in human memory, in The Handbook of the Psychology of Aging (Birren J. E. and Schaire K. W., eds.), pp. 384–420. Van Nostrand Reinhold, New York.
Crapper McLachlan D. R. and De Boni U. (1980) Aluminum in human brain disease—An overview. Neurotoxicology 1, 3–16.
Crapper D. R., Quittkat S., Krishnan S. S., Dalton A. J., and DeBoni U. (1980) Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropthol. 50, 19–24.
Cross A. J., Crow T. J., Ferrier I. N., Johnson J. A., Bloom S. R., and Corsellis J. A. N. (1984) Serotonin receptor changes in dementia of the Alzheimer type. J. Neurochem. 43, 1574–1581.
D’amato R. J., Zweig R. M., Whitehouse P. J., Wenk G. L., Singer H. S., Mayeux R., Price D. L., and Snyder S. H. (1987) Aminergic systems in Alzheimer’s disease and Parkinson’s disease. Ann. Neurol. 22, 229–236.
Davies P. and Maloney A. J. F. (1976) Selective loss of central cholinergic neurons in Alzheimer’s disease. Lancet 2, 1403.
Davis K. L. and Mohs R. C. (1982) Enhancement of memory processes in Alzheimer’s disease with multiple-dose intravenous physostigmine. Am.J Psychiat. 139, 1421–1424.
Decker M. W. (1987) The effects of aging on hippocampal and cortical projections of the forebrain cholinergic system. Brain Res. Rev. 12, 423–438.
Delaney J. F. (1979) Spinal fluid aluminum levels in patients with Alzheimer disease. Ann. Neurol. 5, 580–581.
Dunea G., Mahurkar S. D., Mamdani B., and Smith E. C. (1978) Role of aluminum in dialysis dementia. Ann. Int. Med. 88, 502–504.
Dunne M. P. and Hartley L. R. (1985) The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis. Acta Psychol. 58, 205–217.
Dunnett S. B., Low W. C., Iversen S. D., Stenevi U., and Bjorklund A. (1982) Septal transplants restore maze learning in rats with fonix-fimbria lesions. Brain Res. 251, 335–348.
Dunnett S. B., Rogers D. C., and Jones G. H. (1989) Effects of nucleus basalis magnocellularis lesions in rats on delayed matching and non-matching to position tasks. Eur. J. Neurosci. 1, 395–406.
Ebel A., Strosser M. T., and Kempf E. (1987) Genotypic differences in central neurotransmitter responses to aging mice. Neurobiol. Aging 8, 417–427.
Etienne P., Robitaille Y., Wood P., Gauthier S., Nair N. P. V., and Quirion R, (1986) Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer’s disease. Neurosci. 19, 1279–1291.
Fischer W., Gage F. H., and Bjorklund A. (1989) Degenerative changes in forebrain cholinergic nuclei correlate with cognitive impairments in aged rats. Eur. J. Neurosci. 1, 34–45.
Folstein M. F. and Whitehouse P. J. (1983) Cognitive impairment of Alzheimer disease. Neurobehav. Toxicol. Teratol. 5, 631–634.
Francis P. T., Palmer A. M., Sims N. R., Bowen D. M., Davison A. N., Esiri M. M., Neary D., Snowden J. S., and Wilcock G. K. (1985) Neurochemial studies of early-onset Alzheimer’s disease. N. Engl. J. Med. 313, 7–11.
Freedman M. and Oscar-Berman M. (1986) Selective delayed response deficits in Parkinson’s and Alzheimer’s disease. Arch. Neurol. 43, 886–890.
Gaal G., Potter P. E., Hanin I., Kakucska I., and Vizi E. S. (1986) Effects of intracerebroventricular AF64A administration on cholinergic, serotonergic and catecholaminergic circuitry in rat dorsal hippocampus. Neuroscience 19, 1197–1205.
Gage F. H., Dunnett S. B., and Bjorklund A. (1984a) Spatial learning and motor deficits in aged rats. Neurobiol. Aging 5, 43–48.
Gage F. H., Kelly P. A. T., and Bjorklund A. (1984b) Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats. J. Neurosci. 4, 2856–2865.
Gardiner I. M., de Belleroche J., Premi B. K., and Hamilton M. H. (1987) Effect of lesion of the nucleus basalis of rat on acetylcholine release in cerebral cortex: time course of compensatory events. Brain Res. 407, 263–271.
Godefroy F., Bassant M. H., Weil-Fugazza J., and Lamour Y. (1989) Age-related changes in dopaminergic and serotonergic indices in the rat forebrain. Neurobiol. Aging 10, 187–190.
Gonatas N. K., Anderson W., and Evangelista I. (1967) The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer’s dementia. J. Neuropathol. Exp. Neurol. 26, 25–39.
Handelmann G. E. and Olton D. S. (1981) Recovery of function after neurotoxic damage to the hippocampal CA3 region: Importance of postoperative recovery interval and task experience. Behav. Neural Biol. 33, 453–464.
Henderson Z. (1991) Sprouting of cholinergic axons does not occur in the cerebral cortex after nucleus basalis lesions. Neuroscience 1, 149–156.
Henke H. and Lang W. (1983) Cholinergic enzymes in neocortex, hippocampus and basal forebrain of non-neurological and senile dementia of Alzheimer-type patients. Brain Res. 267, 281–291.
Hepler D. J., Olton D. S., Wenk G. L., and Coyle J. T. (1985) Lesions in nucleus basalis magnocellularis and medial septal area of rats produce qualitatively similar memory impairments. J. Neurosci. 5, 866–873.
Hohmann C. F. and Coyle J. T. (1988) Long-term effects of basal forebrain lesions on cholinergic, noradrenergic and serotonergic markers in mouse neocortex. Brain Res. Bull. 21, 13–20.
Hohmann C. F., Wenk G. L., Lowenstein P., Brown M. E., and Coyle J. T. (1987) Age-related recurrence of basal forebrain lesion-induced cholinergic deficits. Neurosci. Lett. 82, 253–259.
Hoyer S., Oesterreich K., and Wager O. (1988) Glucose metabolism as the site of the primary abnormality in early onset dementia of Alzheimer type? J. Neurol. 235, 143–148.
Hyman B. T., VanHoesen G. W., Damasio A. R., and Barnes C. L. (1984) Alzheimer’s disease: Cell-specific pathology isolates the hippocampal formation. Science 225, 1168–1170.
Irle E. and Markowitsch H. J. (1987) Basal forebrain-lesioned monkeys are severely impaired in tasks of association and recognition memory. Ann Neurol. 22, 735–743.
Jarrard L. E., Kant G. J., Meyerhoff J. L., and Levy A. (1984) Behavioral and neurochemical effects of intraventricular AF64A administration in rats. Pharmacol. Biochem. Behav. 21, 273–280.
Johnston M. V., McKinney M., and Coyle J. T. (1979) Evidence for a cholinergic projection to neocortex from neurons in the basal forebrain. Proc. Natl. Acad. Sci. USA 76, 5392–5396.
Johnston M. V., McKinney M., and Coyle J. T. (1981) Neocortical cholinergic innervation in the rat. Exp. Brain Res. 43, 159–172.
Kemper T. L. (1983) Organization of the neuropathology of the amygdala in Alzheimer’s disease, in Banbury Report. 15: Biological Aspects of Alzheimer’s Disease, pp. 31–35, Cold Spring Harbor Lab., Cold Spring Harbor, NY.
Kidd M. (1963) Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature 197, 192,193.
Kitt C. A., Mitchell S. J., DeLong M. R., Wainer B. H., and Price D. L. (1987) Fiber pathways of basal forebrain cholinergic neurons in monkeys. Brain Res. 406, 192–206.
Kitt C. A., Struble R. G., Cork L. C., Mobley W. C., Walker L. C., Joh T. H., and Price D. L. (1985) Catecholaminergic neurites in senile plaques in prefrontal cortex of aged nonhuman primates. Neuroscience 16, 691–699.
Kiyosawa M., Pappata S., Duverger D., Riche D., Cambon H., Mazoyer B., Samson Y., Crouzel C., Naquet R., MacKenzie E.T., and Baron J-C. (1987) Cortical hypometabolism and its recovery following nucleus basalis lesions in baboons: A PET study. J. Cerebral Blod Flow Metabol. 7, 812–817.
Kohler C. and Schwartz R. (1983) Comparison of ibotenate and kainate neurotoxicity in rat brain: A histological study. Neuroscience 8, 819–835.
Lamarca M. V. and Fibiger H. C. (1984) Deoxyglucose uptake and choline acetyltransferase activity in cerebral cortex following lesions of the nucleus basalis magnocellularis. Brain Res. 307, 366–369.
Lenders M.-B., Peers M.-C., Tramu G., Delacourte A., Defossez A., Petit H., and Mazzuca M. (1989) Dystrophic peptidergic neurites in senile plaques of Alzheimer’s disease hippocampus precede formation of paired helical filaments. Brain Res. 481, 344–349.
Leong S. F., Lai J. C. K., Lim L., and Clark J. B. (1981) Energy-metabolizing enzymes in brain regions of adult and aging rats. J. Neurochem. 37, 1548–1556.
Levy A., Kant G. J., Meyerhoff J. L., and Jarrard L. E. (1984) Noncholinergic neurotoxic effects of AF64A in substantia nigra. Brain Res. 305, 169–172.
Lindner M. D. and Schallert T. (1988) Aging and atropine effects on spatial navigation in the Morris water task. Behav. Neurosci. 102, 621–634.
London E. D., McKinney M., Dam M., Ellis A., and Coyle J. T. (1984) Decreased cortical glucose utilization after ibotenate lesion of the rat ventromedial globus pallidus. J. Cerebr. Blood Flow Metab. 4, 381–390.
Mantione C. R., Fisher A., and Hanin I. (1981) The AF64A-treated mouse: possible model for central cholinergic hypofunction. Science 13, 579–580.
Markowska A. L., Stone W. S., Ingram D. K., Reynolds J., Gold P. E., Conti L. H., Pontecorvo M. J., Wenk G. L., and Olton D. S. (1989) Individual differences in aging: Behavioral and neurobiological correlates. Neurobiol. Aging 10, 31–43.
Martinez J. L., Schulteis G., Janak P. H., and Weinberger S. B. (1988) Behavioral assessment of forgetting in aged rodents and its relationship to peripheral sympathetic function. Neurobiol. Aging 9, 697–708.
Mason S. T. and Fibiger H. C. (1979) On the specificity of kainic acid. Science 20, 1339–1341.
McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E. M. (1984) Clinical diagnosis of Alzheimer’s disease. Neurology 34, 939–944.
McGurk S. R., Hartgraves S. L., Kelly P. H., Gordon M. N., and Butcher L. L. (1987) Is ethylcholine mustard aziridinium ion a specific cholinergic neurotoxin? Neuroscience 22, 215–224.
Mesulam M. M., Mufson E. J., Levey A. I., and Wainer B. H. (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nuclei basalis (substantia innominata) and hypothalamus in rhesus monkey. J. Comp. Neurol. 214, 170–197.
Mesulam M. M., Mufson E. J., Levey A. I., and Wainer B. H. (1984) Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience 12, 669–686
Meyers D., Armstrong R. A., Smith C. U. M., and Carter R. A. (1988) The spatial arrangement pattern of senile plaques in senile dementia of the Alzheimer type (SDAT). Neurosci. Res. Comm. 2, 99–106
Michalek H., Fortuna S., and Pintor A. (1989) Age-related differences in brain choline acetyltransferase, cholinesterase and muscarinic receptor sites in two strains of rats. Neurobiol. Aging 10, 143–148.
Mitchell S. J., Rawlins J. N. P., Steward O., and Olton D. S. (1982) Medial septal area lesions disrupt theta rhythm and cholinergic staining in medial entorhinal cortex and produce impaired radial arm maze behavior in rats. J. Neurosci. 2, 292–302.
Moretti A., Carfagna N., and Trunzo F. (1987) Effects of monoamines and their metabolites in the rat brain. Neurosci. Res. 12, 1035–1039.
Mufson E. J., Kehr A. D., Wainer B. R, and Mesulam M.-M. (1987) Cortical effects of neurotoxic damage to the nucleus basalis in rats: persistent loss of extrinsic cholinergic input and lack of transsynaptic effect upon the number of somatostatin-containing, cholinesterase-positive, and cholinergic cortical neurons. Brain Res. 417, 385–388.
Nemeroff C. B., Kizer J. S., Reynolds G. P., and Bissette G. (1989) Neuropeptides in Alzheimer’s disease: a postmortem study. Reg. Peptides 25, 123–130.
Ojima H., Sakurai T., and Yamasaki T. (1988) Changes in choline acetyltransferase immunoreactivity and the number of immunoreactive fibers remaining after lesions of the magnocellular basal nucleus of rats. Neurosci. Lett. 95, 31–36.
Okaichi H. and Jarrard L. E. (1982) Scopolamine impairs performance of a place and cue task in rats. Behav. Neural Biol. 35, 1982.
Olney J. W., Rhee V., and Ho O. L. (1974) Kainic acid: a powerful neurotoxic analogue of glutamate. Brain Res. 77, 507–512.
Olton D. S. (1986) Interventional approaches to memory: Lesions, in Learning and Memory: A Biological View (Martinez J. L. and Kesner R., eds.), pp. 379–397, Academic, New York.
Olton D. S., Walker J. A., and Wolf W. A. (1982) A disconnection analysis of hippocampal function. Brain Res. 233, 241–253.
Olton D. S. and Wenk G. L. (1987) Dementia: Animal models of the cognitive impairments produced by degeneration of the basal forebrain cholinergic system, in Psychopharmacology: The Third Generation of Progress (Meltzer H.Y., ed.), pp. 941–953, Raven, New York.
Olton D. S., Wenk G. L., Church R. M., and Meek W. H. (1988) Attention and the frontal cortex as examined by simultaneous temporal processing. Newpsychology 26, 307–318.
Owen M. J. and Butler S. R. (1981) Amnesia after transection of the fornix in monkeys: long-term memory impaired, short-term memory intact. Behav. Brain Res. 3, 115–123.
Pearson R. C. A., Neal J. W., and Powell T. P. S. (1986) Hypertrophy of cholinergic neurones of the basal nucleus in the rat following damage of the contralateral nucleus. Brain Res. 382, 149–152.
Pedata F., LoConte G., Sorbi S., Marconcini Pepeu I., and Pepeu G. (1982) Changes in high affinity choline uptake in rat cortex following lesions of the magnocellular forebrain nuclei. Brain Res. 233, 359–367.
Pendlebury W. W., Beal M. F., Kowall N. W., and Soloman P. R. (1988) Neuropathologic, neurochemical and immunocytochemical characteristics of aluminum-induced neurofilamentous degeneration. Neurotoxicology 9, 503–510.
Perkins M. N. and Stone T. W. (1983) Quinolinic acid: regional variations in neuronal sensitivity. Brain Res. 259, 172–176.
Perry E. K. and Perry R. H. (1985) New insights into the nature of senile (Alzheimer-type) plaques. Trends Neurosci. 10, 301–303.
Piercey M. F., Vogelsang G. D., Franklin S. R., and Tang A. H. (1987) Reversal of scopolamine-induced amnesia and alterations in energy metabolism by the nootropic piracetam: Implications regarding identification of brain structures involved in consolidation of memory traces. Brain Res. 42, 1–9.
Preston G. C., Brazell C., Ward C., Broks P., Traub M., and Stahl S. M. (1988) The scopolamine model of dementia: determination of central cholinomimetic effects of physostigmine on cognition and biochemical markers in man. J. Psychopharmacol. 2, 67–79.
Price D. L. (1986) New perspectives on Alzheimer’s disease. Ann. Rev. Neurosci. 9, 489–512.
Rapp P. R., Rosenberg R. A., and Gallagher M. (1987) An evaluation of spatial information processing in aged rats. Behav. Neurosci. 101, 3–12.
Ridley R. M., Baker H. F., Drewett B., and Johnson J. A. (1985) Effects of ibotenic acid lesions of the basal forebrain serial reversal learning in marmosets. Psychopharmacology 86, 438–443.
Ridley R. M., Murray T. K., Johnson J. A., and Baker H. F. (1986) Learning impairment following lesion of the basal nucleus of Meynert in the marmoset: Modification by cholinergic drugs. Brain Res. 376, 108–116.
Roudier M., Marcie P., Podrabinek N., Lamour Y., and Davous P. (1988) Correlations between memory, language, agnosia, and apraxia in 80 patients with senile dementia of the Alzheimer type. Drug Develop. Res. 14, 231–234.
Rusted J. M. (1988) Dissociative effects of scopolamine on working memory in healthy young volunteers. Psychopharmacology 96, 487–492.
Saletu B., Grunberger J., Linzmayer L., and Anderer P. (1979) Proof of CNS efficacy and pharmacodynamics of nicergoline in the elderly by acute and chronic quantitative pharmaco-EEG and psychometric studies, in Drug Treatment and Prevention in Cerebrovascular Disorders (Tognoni G. and Garattini S., eds.), pp. 245–272, Elsevier/North Holland, Amsterdam.
Sandberg K., Hanin I., Fisher A., and Coyle J. T. (1984) Selective cholinergic neurotoxin: AF64A’s effects in rat striatum. Brain Res. 293, 49–55.
Sandberg K., Schnaar R. L., McKinney M., Hanin I., Fisher A., and Coyle J. T. (1985) AF64A: An active site directed irreversible inhibitor of choline acetyltransferase. J. Neurochem. 44, 439–445.
Satoh K. and Fibiger H. C. (1985) Distribution of central cholinergic neurons in the baboon (Papio): I. General morphology. J. Comp. Neurol. 236, 197–214.
Schwartz R. and Kohler C. (1983) Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett. 38, 85–90.
Schwartz R., Scholz D., and Coyle J. T. (1978) Structure-activity relations for the neurotoxicity of kainic acid derivatives and glutamate analogues. Neuropharmacology 17, 145–151.
Simon J. R. and Kuhar M. J. (1975) Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminal. Nature 255, 162–163.
Sirvio J., Valjakka A., Jolkkonen J., Jervonen A., and Riekkinen P. J. (1988) Cholinergic enzyme activities and muscarinic binding in the cerebral cortex of rats of different age and sex. Comp. Biochem. Physiol. 90C, 245–248.
Smith C. M. and Swash M. (1978) Possible biochemical basis of memory disorder in Alzheimer Disease. Ann. Neurol. 3, 471–473.
Smith G. (1988) Animal models of Alzheimer’s disease: experimental cholinergic denervation. Brain Res. Rev. 13, 103–118.
Spangler E. L., Rigby P., and Ingram D. K. (1986) Scopolamine impairs learning performance of rats in a 14-unit T-maze. Pharmcol. Biochem. Behav. 25, 673–679.
Spignoli G. and Pepeu G. (1987) Interactions between oxiracetam, aniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol. Biochem. Behav. 27, 491–495.
Struble R. G., Cork L. C., Whitehouse P. J., and Price D. L. (1982) Cholinergic innervation of neuritic plaques. Science 216, 413–415.
Struble R. G., Powers R. E., Casanova M. F., Kitt C. A., Brown E. C., and Price D. L. (1987) Neuropeptidergic systems in plaques of Alzheimer’s disease. J. Neuropathol. Exp. Neurol. 46, 567–584.
Struble R. G., Price Jr., D. L., Cork L. C., and Price D. L. (1985) Senile plaques in cortex of aged normal monkeys. Brain Res. 361, 267–275.
Summers W. K., Majovski L. V., Marsh G. M., Tachiki K., and Kling A. (1987) Oral tetrahydroaminoacridine in long-term treatment of Alzheimer’s disease. New Engl. J. Med. 315, 1241–1245.
Tay S. S. W., Williams T. H., and Jew J.Y. (1989) Neurotensin immunoreactivity in the central nucleus of the rat amygdala: An ultrastructural approach. Peptides 10, 113–120.
Terry R. D. and Davies P. (1980) Dementia of the Alzheimer type. Ann. Rev. Neurosci. 3, 77–95.
Terry R. D. and Pena C. (1965) Experimental production of neurofibrillary degeneration. Neuropathol. Exp. Neural. 24, 200–210.
Terry R. D., Mandel R. J., Buzsaki G., Gage F. H., and Thal L. J. (1988) Characterization of the effects of nucleus basalis lesions in rats 14 months post-lesion. Soc. Neurosci. Abstr. 1, 1007.
Thal L. J., Rosen W, and Sharpless N. S. (1981) Choline chloride fails to improve cognition in Alzheimer’s disease. Neurobiol. Aging 2, 205–208.
Trapp G. A., Miner G. D., Zimmerman R. L., Mastri A. R., and Heston L. L. (1978) Aluminum levels in brain in Alzheimer’s disease. Biol. Psychiat. 13, 709–718.
Troncoso J. G, Price D. L., Griffin J. W., and Parhad I. M. (1982) Neurofibrillary axonal pathology in aluminum intoxication. Ann. Neurol. 12, 278–283.
Tucek S. (1978) Acetylcholine Synthesis in Neurons. Chapman and Hall, London.
Ulrich J. and Stahelin H. B. (1984) The variable topography of Alzheimer type changes in senile dementia and normal old age. Gerontology 30, 210–214.
Vanella A., Villa R. F., Gorini A., Campisi A., and Giuffrida-Stella A. M. (1989) Superoxide dismutase and cytochrome oxidase activities in light and heavy synaptic mitochondria from rat cerebral cortex during aging. J. Neurosci. Res. 22, 351–355.
Villani L., Contestabile A., Migani P., Poli A., and Fonnum F. (1986) Ultra-structural and neurochemical effects of the presumed cholinergic toxin AF64A in the rat interpeduncular nucleus. Brain Res. 379, 223–231.
Walker L. C., Kitt C. A., Cork L. C., Struble R. G., Dellovade T. L., and Price D. L. (1988a) Multiple transmitter systems contribute neurites to individual senile plaques. J. Neuropathol. Exe. Neurol. 47, 138–144.
Walker L. C., Kitt C. A., Struble R. G., Wagster M. V., Price D. L., and Cork, L. C. (1988b) The neural basis of memory decline in aged monkeys. Neurobiol. Aging 9, 657–666.
Walker L. C., Koliatsos V. E., Kitt G A., Richardson R. T., Rokaeus A., and Price D. L. (1989) Peptidergic neurons in the basal forebrain magnocellular complex of the rhesus monkey. J. Comp. Neurol. 280, 272–282.
Wenk G. L. (1989) An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Psychopharmcology 99, 431–438.
Wenk G. L., Cribbs B., and McCall L. (1984) Nucleus basalis magnocellularis: Optimal coordinates for selective reduction of choline acetyltransferase in frontal neocortex by ibotenic acid injections. Ex. Brain Res. 56, 335–340.
Wenk G. L. and Engisch K. L. (1986) [3H] Ketanserin (serotonin type 2) binding increases in rat cortex following basal forebrain lesions with ibotenic acid. J. Neurochem. 47, 845–850.
Wenk G. L., Engisch K. L., McCall L. D., Mitchell S. J., Aigner T. G., Struble R. L., Price D. L., and Olton D. S. (1986) [3H] Ketanserin binding increases in monkey cortex following basal forebrain lesions with ibotenic acid. Neurochem. Int. 9, 557–562.
Wenk G. L., Hughey D., Boundy V., Kim A., Walker L., and Olton D. (1987) Neurotransmitters and memory: Role of cholinergic, serotonergic, and noradrenergic systems. Behav. Neurosci. 101, 325–332.
Wenk G. L., Markowska A. L., and Olton D. S. (1989a) Basal forebrain lesions and memory: Alterations in neurotensin, not acetylcholine, may cause amnesia. Behav. Neurosci. 103, 765–769.
Wenk G. L. and Olton D. S. (1984) Recover of neocortical choline acetyltransferase activity following ibotenic acid injection in the nucleus basalis of Meynert in rats. Brain Res. 293, 184–186.
Wenk G. L. and Olton D. S. (1987) Basal forebrain cholinergic neurons and Alzheimer’s disease, in Animal Models of Dementia (Coyle J.T., ed.), pp. 81–101, Liss, New York.
Wenk G. L., Pierce D. J., Struble R. G., Price D. L., and Cork L. C. (1989b) Age-related changes in multiple neurotransmitter systems in the monkey brain. Neurobiol. Aging 10, 11–19.
Wenk G. L. and Rokaeus A. (1988) Basal forebrain lesions differentially alter galanin levels and acetylcholinergic receptors in the hippocampus and neocortex. Brain Res. 460, 17–21.
Wesnes K. and Warburton D. M. (1983) Effects of scopolamine on stimulus sensitivity and response in a visual vigilance task. Neuropsychobiology 9, 154–157.
Wesnes K. and Warburton D. M. (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology 82, 147–150.
Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., and DeLong M. R. (1981) Alzheimer Disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10, 122–126.
Whitehouse P. J,, Struble R. G., Hedreen J. C., Clark A. W., and Price D. L. (1985) Alzheimer’s disease and related dementias: selective involvement of specific neuronal systems. CRC Critical Rev. Clin. Neurobiol. 1, 319–339.
Yates C. M., Simpson J., Gordon A., Maloney A. F. J., Allison Y., Ritchie I. M., and Urquhart A. (1983) Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and Down’s syndrome. Brain Res 280, 119–126.
Yokel R. A. (1983) Repeated systemic aluminum exposure effects on classical conditioning of the rabbit. Neurobehav. Toxicol. Teratol. 5, 41–46.
Yokel R. A., Provan S. D., Meyer J. J., and Campbell S. R. (1988) Aluminum intoxication and the victim of Alzheimer’s disease: similarities and differences. Neurotoxicology 9, 429–442.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 The Humana Press Inc.
About this protocol
Cite this protocol
Wenk, G.L. (1992). Animal Models of Alzheimer’s Disease. In: Boulton, A.A., Baker, G.B., Butterworth, R.F. (eds) Animal Models of Neurological Disease, I. Neuromethods, vol 21. Humana Press, Totowa, NJ. https://doi.org/10.1385/0-89603-208-6:29
Download citation
DOI: https://doi.org/10.1385/0-89603-208-6:29
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-208-8
Online ISBN: 978-1-59259-626-3
eBook Packages: Springer Protocols